Page 52 - Simplicity is Key in CRT

52
References
1. Brignole, M., et al., 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J, 2013. 34(29): p. 2281-329.
2. Ponikowski, P., et al., 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J, 2016. 37(27): p. 2129-200.
3. Birnie, D.H., et al., Impact of QRS morphology and duration on outcomes after cardiac resynchronization therapy: Results from the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail, 2013. 6(6): p. 1190-8.
4. Gold, M.R., et al., Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart
failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
Circulation, 2012. 126(7): p. 822-9.
5. Goldstein, R.E., et al., Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of
MADIT-CRT defined by baseline conduction and 1-year post-treatment left ventricular remodeling. Heart Rhythm, 2013.
10(3): p. 366-73.
6. Zareba, W., et al., Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the MultiCentre Automatic
Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation, 2011. 123(10): p. 1061-72.
7. Surawicz, B., et al., AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J
Am Coll Cardiol, 2009. 53(11): p. 976-81.
8. Strauss, D.G., R.H. Selvester, and G.S. Wagner, Defining left bundle branch block in the era of cardiac resynchronization
therapy. Am J Cardiol, 2011. 107(6): p. 927-34.
9. Vanbelle, S. and E. Lesaffre, Modeling agreement on categorical scales in the presence of random scorers. Biostatistics,
2016. 17(1): p. 79-93.
10. Eschalier, R., et al., Nonspecific intraventricular conduction delay: Definitions, prognosis, and implications for cardiac
resynchronization therapy. Heart Rhythm, 2015. 12(5): p. 1071-9.
11. Migliore, F., et al., Prevalence of true left bundle branch block in current practice of cardiac resynchronization therapy
implantation. J Cardiovasc Med (Hagerstown), 2016. 17(7): p. 462-8.
12. Bertaglia, E., et al., Stricter criteria for left bundle branch block diagnosis do not improve response to CRT. Pacing Clin
Electrophysiol, 2017. 40(7): p. 850-856.
13. Tomlinson, D.R., et al., Accuracy of manual QRS duration assessment: its importance in patient selection for cardiac
resynchronization and implantable cardioverter defibrillator therapy. Europace, 2009. 11(5): p. 638-42.
14. Mafi Rad, M., et al., Vectorcardiographic QRS area identifies delayed left ventricular lateral wall activation determined by
electroanatomic mapping in candidates for cardiac resynchronization therapy. Heart Rhythm, 2016. 13(1): p. 217-25.
15. Jackson, T., et al., A U-shaped type II contraction pattern in patients with strict left bundle branch block predicts super-
response to cardiac resynchronization therapy. Heart Rhythm, 2014. 11(10): p. 1790-7.
16. van Deursen, C.J., et al., Vectorcardiographic QRS area as a novel predictor of response to cardiac resynchronization
therapy. J Electrocardiol, 2015. 48(1): p. 45-52.
17. Bogale, N., et al., The European cardiac resynchronization therapy survey: patient selection and implantation practice vary
according to centre volume. Europace, 2011. 13(10): p. 1445-53.
18. Curtis, A.B., et al., Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J,
2009. 158(6): p. 956-64.
19. Cleland, J.G., et al., An individual patient meta-analysis of five randomized trials assessing the effects of cardiac
resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J, 2013.
34(46): p. 3547-56.
20. Engels, E.B., et al., The synthesized vectorcardiogram resembles the measured vectorcardiogram in patients with
dyssynchronous heart failure. J Electrocardiol, 2015. 48(4): p. 586-92.
21. Epstein, A.E., et al., 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-
based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol, 2013. 61(3): p. e6-75.